Grantham, Mayo, Van Otterloo & Co (GMO)’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-647,749
Closed -$58.1M 788
2021
Q4
$58.1M Buy
+647,749
New +$55M 0.28% 57

Other funds holding CONE

Grantham, Mayo, Van Otterloo & Co (GMO)'s CONE Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 647,749 shares — an estimated $58.1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CONE in Q4 2021 and held it in 1 quarter. The position peaked at $58.1M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 647,749 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $58.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CyrusOne Inc Common Stock in Q4 2021 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CyrusOne Inc Common Stock position peaked at $58.1M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.